/4591.T
4591.T Stock - Ribomic Inc.
Healthcare|BiotechnologyJPX
$74.00+0.00%
+$0.00 (+0.00%) • Dec 24
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.6
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $81.40
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 4591.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$73.26 – $74.74
TARGET (TP)$85.10
STOP LOSS$68.08
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.18
52W High$141.00
52W Low$72.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.11M | N/A | $65.97M | $80.91M | $91.96M |
| Gross Profit | $2.11M | $-10,502,000 | $65.97M | $80.91M | $91.96M |
| Gross Margin | 100.0% | N/A | 100.0% | 100.0% | 100.0% |
| Operating Income | $-1,050,589,000 | $-1,116,193,000 | $-1,786,041,000 | $-1,748,112,000 | $-1,239,643,000 |
| Net Income | $-1,018,939,000 | $-1,024,237,000 | $-1,653,002,000 | $-1,684,754,000 | $-1,187,194,000 |
| Net Margin | -48359.7% | N/A | -2505.7% | -2082.3% | -1290.9% |
| EPS | $-25.21 | $-28.70 | $-53.14 | $-59.95 | $-46.17 |
Company Overview
Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan. The company develops drugs for wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma, as well as separating agents for affinity purification of human IgG and Fc-fusion proteins. Ribomic Inc. was incorporated in 2003 and is headquartered in Tokyo, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
4591.TBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-6.09
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 12, 2025 | — | $-6.09 | — | — |
Q3 2025 | Aug 12, 2025 | — | $-5.10 | — | — |
Q2 2025 | May 13, 2025 | — | $-6.33 | — | — |
Q1 2025 | Feb 11, 2025 | — | $-6.26 | — | — |
Q4 2024 | Nov 12, 2024 | — | $-5.62 | — | — |
Q3 2024 | Aug 9, 2024 | — | $-6.97 | — | — |
Q2 2024 | May 14, 2024 | — | $-6.20 | — | — |
Q1 2024 | Feb 13, 2024 | — | $-6.95 | — | — |
Q4 2023 | Nov 13, 2023 | — | $-6.16 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-9.39 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-4.95 | — | — |
Q1 2023 | Feb 10, 2023 | — | $-18.87 | — | — |
Q4 2022 | Nov 11, 2022 | — | $-9.29 | — | — |
Q3 2022 | Aug 9, 2022 | — | — | — | — |
Q2 2021 | May 13, 2021 | — | — | — | — |
Q1 2021 | Feb 12, 2021 | — | — | — | — |
Q4 2020 | Nov 12, 2020 | — | — | — | — |
Q3 2020 | Aug 7, 2020 | — | — | — | — |
Q2 2018 | May 14, 2018 | — | — | — | — |
Latest News
Loading news...
Frequently Asked Questions about 4591.T
What is 4591.T's current stock price?
Ribomic Inc. (4591.T) is currently trading at $74.00 per share. The stock has moved +0.00% today.
What is the analyst price target for 4591.T?
No analyst price targets are currently available for this stock.
What sector is Ribomic Inc. in?
Ribomic Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the JPX exchange.
What is 4591.T's market cap?
Ribomic Inc. has a market capitalization of $3.50 billion, making it a mid-cap company.
Does 4591.T pay dividends?
No, Ribomic Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector206A.T
PRISM BioLab Co.,LTD
$148.00
Mkt Cap: $5.4B
2342.T
Trans Genic Inc.
$254.00
Mkt Cap: $4.2B
4570.T
Immuno-Biological Laboratories Co., Ltd.
$1404.00
Mkt Cap: $13.1B
4572.T
Carna Biosciences, Inc.
$415.00
Mkt Cap: $7.9B
4576.T
D. Western Therapeutics Institute, Inc.
$93.00
Mkt Cap: $4.1B
4596.T
Kubota Pharmaceutical Holdings Co., Ltd.
$42.00
Mkt Cap: $2.5B
4598.T
Delta-Fly Pharma, Inc.
$500.00
Mkt Cap: $5.7B
4881.T
FunPep Company Limited
$77.00
Mkt Cap: $3.1B
4882.T
Perseus Proteomics Inc.
$220.00
Mkt Cap: $3.2B
4884.T
Kringle Pharma, Inc.
$378.00
Mkt Cap: $2.6B
Explore stocks similar to 4591.T for comparison